Published in Cancer on February 15, 1987
Spontaneous regression of malignant tumors: Importance of the immune system and other factors (Review). Oncol Lett (2010) 1.16
Vaginal recurrence more than 17 years after hysterectomy and adjuvant treatment for uterine carcinoma with successful salvage brachytherapy: a case report. Case Rep Oncol (2011) 0.87
Pelvic recurrence of stage 1a well-differentiated endometrial carcinoma after 13 years: A case report. J Turk Ger Gynecol Assoc (2016) 0.77
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med (1983) 8.82
Purification and properties of rat liver microsomal stearyl coenzyme A desaturase. Proc Natl Acad Sci U S A (1974) 3.18
Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A (1993) 2.86
Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol (1996) 2.77
Minilaparotomy for the ambulatory management of ovarian cysts. Am J Obstet Gynecol (1995) 2.72
BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science (1999) 2.54
Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology (1997) 2.18
Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect Immun (1996) 1.98
Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Res (1984) 1.83
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene (2001) 1.82
CA125 antigen levels in obstetric and gynecologic patients. Obstet Gynecol (1984) 1.61
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. Am J Obstet Gynecol (1984) 1.60
Cancer of the uterine cervix. N Engl J Med (1996) 1.59
Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Cancer Res (2000) 1.56
Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer (1999) 1.52
Expression of interleukin-1beta in human breast carcinoma. Cancer (1997) 1.52
Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer (1997) 1.50
Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res (2000) 1.46
Incidence and predictors of cervical dysplasia in patients with minimally abnormal Papanicolaou smears. Obstet Gynecol (1998) 1.45
Cellular senescence in a cloned strain of bovine fetal aortic endothelial cells. Science (1980) 1.41
Three-dimensional structure of Fab R19.9, a monoclonal murine antibody specific for the p-azobenzenearsonate group. Proc Natl Acad Sci U S A (1989) 1.35
Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer. Am J Obstet Gynecol (1985) 1.32
The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase. Oncogene (2000) 1.31
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen. Am J Obstet Gynecol (1984) 1.30
BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer (2006) 1.27
Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer (1998) 1.26
Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene (2007) 1.24
Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril (1986) 1.19
BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins. Oncogene (1998) 1.18
Response of avian embryonic brain to spatially segmented x-ray microbeams. Cell Mol Biol (Noisy-le-grand) (2001) 1.15
Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene (1997) 1.14
The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. Mol Cell Biol (2001) 1.13
Modulation of HGF-induced tubulogenesis and branching by multiple phosphorylation mechanisms. Dev Biol (1993) 1.13
Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett (2001) 1.12
Identification of cervical intraepithelial neoplasia (CIN) using UV-excited fluorescence and diffuse-reflectance tissue spectroscopy. Lasers Surg Med (2001) 1.12
Relationship of VH and VL genes encoding three idiotypic families of anti-p-azobenzenearsonate antibodies. Proc Natl Acad Sci U S A (1986) 1.11
Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest (1997) 1.10
Signal transduction in c-met mediated motogenesis. EXS (1993) 1.10
Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene (1998) 1.10
Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells. Breast Cancer Res Treat (2000) 1.09
Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children. Pediatrics (1998) 1.06
The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer. Am J Obstet Gynecol (1986) 1.06
Proliferative characteristics of clonal endothelial cell strains. J Cell Physiol (1981) 1.05
Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Oncogene (1998) 1.04
Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int J Dev Neurosci (1999) 1.02
Psychosocial factors, curative therapies, and behavioral outcomes. A comparison of testis cancer survivors and a control group of healthy men. Cancer (1989) 1.01
Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience. J Clin Oncol (1984) 1.01
Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma. Proc Natl Acad Sci U S A (1994) 1.00
Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells. J Nutr (2000) 1.00
Effect of scatter factor and hepatocyte growth factor on motility and morphology of MDCK cells. In Vitro Cell Dev Biol (1992) 1.00
Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes. J Mol Med (Berl) (2000) 0.99
Relationship between obesity and uterine leiomyomata. Nutrition (1992) 0.98
Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding. Oncogene (2001) 0.98
Candida funisitis: A clinicopathologic study of 32 cases. Pediatr Dev Pathol (1999) 0.97
A chimeric mouse-human antibody that retains specificity for HIV gp120 and mediates the lysis of HIV-infected cells. J Immunol (1989) 0.96
Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst (1995) 0.94
Scatter factor binds to thrombospondin and other extracellular matrix components. Am J Pathol (1996) 0.94
Immunosuppression: a cause of porokeratosis? J Am Acad Dermatol (1985) 0.91
Altered gene expression pattern in cultured human breast cancer cells treated with hepatocyte growth factor/scatter factor in the setting of DNA damage. Cancer Res (2001) 0.91
Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53. Int J Radiat Biol (1999) 0.91
Stimulation of cell invasion and migration by alcohol in breast cancer cells. Biochem Biophys Res Commun (2000) 0.91
Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1. Oncogene (2001) 0.90
Effect of hepatocyte growth factor/scatter factor and other growth factors on motility and morphology of non-tumorigenic and tumor cells. In Vitro Cell Dev Biol Anim (1994) 0.90
Isolation and culture of a tetraploid subpopulation of smooth muscle cells from the normal rat aorta. Science (1984) 0.88
Endometrial carcinoma: analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy. Obstet Gynecol (1993) 0.87
Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage. Oncogene (2007) 0.87
Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation. Int J Cancer (1998) 0.86
Scatter factor protein levels in human breast cancers: clinicopathological and biological correlations. Am J Pathol (1996) 0.86
Primary structure of IgE monoclonal antibodies expressing an intrastrain crossreactive idiotype. J Exp Med (1986) 0.85
Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrence. Gynecol Oncol (1989) 0.85
Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells. Clin Exp Metastasis (2000) 0.84
Reliability of placental histology using archived specimens. Paediatr Perinat Epidemiol (1999) 0.84
Influence of local-regional lymph node metastases on prognosis in neuroblastoma. Med Pediatr Oncol (1984) 0.83
P53-independent down-regulation of Mdm2 in human cancer cells treated with adriamycin. Mol Cell Biol Res Commun (2000) 0.83
CA 125 serum levels correlated with second-look operations among ovarian cancer patients. Obstet Gynecol (1986) 0.82
Purification, characterization and mechanism of action of scatter factor from human placenta. EXS (1991) 0.82
HGF-SF: effects on motility and morphology of normal and tumor cells. EXS (1993) 0.82
Stage IV-N: a favorable subset of children with metastatic neuroblastoma. Med Pediatr Oncol (1985) 0.81
Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells. Oncogene (2006) 0.80
Regulation of angiotensin I-converting enzyme activity in serially cultivated bovine endothelial cells. J Cell Physiol (1985) 0.80
Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells. Prostate (1999) 0.80
Possible benefit of doxorubicin treatment in patients with refractory germ cell cancer. Cancer (1986) 0.80
Whole abdominal irradiation for tumors of the uterine corpus. Cancer (1988) 0.80
Immunologic responses to gene transfer into mice via the polymeric immunoglobulin receptor. Gene Ther (1996) 0.79
Cardiac disease after mediastinal irradiation for seminoma. Cancer (1987) 0.79
Scatter factor is a glycoprotein but glycosylation is not required for its activity. Biochim Biophys Acta (1992) 0.79
P53-independent downregulation of p73 in human cancer cells treated with Adriamycin. Cancer Chemother Pharmacol (2001) 0.79
Rat placental hepatocyte growth factor/scatter factor: purification, characterization, and developmental regulation. Proc Soc Exp Biol Med (1993) 0.78
Hepatocyte growth factor/scatter factor blocks the mitochondrial pathway of apoptosis signaling in breast cancer cells. J Biol Chem (2001) 0.78
Cytogenetic and molecular genetic characterization of trisomy 20 mosaicism in fetal blood and tissues. Prenat Diagn (1996) 0.78
Radiation survival of vascular smooth muscle cells as a function of age. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 0.78
Radiation survival properties of cultured vascular smooth muscle cells. Radiat Res (1984) 0.78
Stroke due to treatment with L-asparaginase in an adult. N Engl J Med (1982) 0.78
Chemotherapy of refractory germ cell cancer with Etoposide. J Clin Oncol (1983) 0.78
Long-term survival in peritoneal mesothelioma. The role of radiotherapy and combined modality treatment. Cancer (1987) 0.77
Outpatient minilaparotomy for ovarian cysts. J Reprod Med (1999) 0.77
Hepatocyte growth factor decreases sensitivity to chemotherapeutic agents and stimulates cell adhesion, invasion, and migration. Biochem Biophys Res Commun (2000) 0.76
Hepatocyte growth factor-scatter factor (HGF-SF) and the c-met receptor. Introduction. EXS (1993) 0.76